Memphasys (ASX:MEM)
ASX announcement history & article coverage
Transparent by design.
Announcments by Memphasys (ASX:MEM) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 4G and Corporate Governance Statement
Appendix 4E and 2026 Annual Report
Memphasys reports FY2026 revenue surge, narrows net loss, advances Felix™ commercialisation
Felix Early Thai FDA Approval, Commercial Launch Accelerates
Memphasys secures early Thai FDA approval for Felix™ System, activating exclusive distribution deal with IVF Envimed
Results of General Meeting
Felix Registration Achieved in Vietnam and Cartridge Order
Memphasys secures Vietnam registration for Felix™ System, triggers first 600-cartridge commercial order
Pivotal Felix Study Receives First Scientific Presentation
European Commercial Roll-out continues with Poland Agreement
Memphasys Secures Exclusive Felix™ Commercialisation Deal in Poland Worth A$350,000
Proposed issue of securities - MEM
Notice of General Meeting/Proxy Form
Quarterly Activities/Appendix 4C Cash Flow Report
Memphasys reports record revenue, largest Felix™ deal with Monash IVF, and expands global footprint
Becoming a substantial holder
Memphasys Enters into Consulting Agreement with Director
Exclusive Thailand Commercialisation Agreement Secured
Memphasys secures exclusive three-year Felix™ distribution deal in Thailand worth A$430K
Section 708A Cleansing Statement
Application for quotation of securities - MEM
UK Market Entry & Acceleration of Commercial Expansion
Memphasys accelerates UK market entry with Felix™ System trials and initial orders
Investor Presentation - June 2026
Memphasys Investor Webinar
Proposed issue of securities - MEM
Successful $1.2M Placement and Convertible Note Extended
Memphasys Raises $1.2M to Support Felix™ Commercial Expansion and Extends Convertible Note
Trading Halt
Pause in Trading
Memphasys Limited trading halt announced
Memphasys Executes Supply Agreement with Monash IVF Group
Memphasys signs exclusive 12-month supply deal with Monash IVF for Felix™ system
South-East Asian Commercialization Agreement Secured
Memphasys Signs $530,000 Exclusive Felix™ Commercialisation Deal in Vietnam
